
Fitish Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.2/10
Best for: all-inclusive compounded GLP-1 with nationwide shipping
Fitish scores highest on state availability and ease of access.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Fitish offers compounded semaglutide ($219/28 days) and compounded tirzepatide ($339/28 days) including consultation and shipping. LegitScript certified. Ships to all US states. Also offers GLP-1 microdosing.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Fitish
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Fitish at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $219/mo (A separate microdose lane is $179/mo and does not titrate up.)
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- 1 FDA warning letter on record — see below
How we scored Fitish
Each dimension is scored algorithmically from Fitish’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.4/10At $219/mo, Fitish runs about 30% above the $169 median for GLP-1 providers.
Effectiveness25%
8.4/10Fitish offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.6/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.3/10Key details fully confirmed by our editors; an FDA warning letter is on file (see flag above) (last checked 2026-08-16).
Accessibility10%
8.5/10Fitish treats patients in all 50 states.
Support10%
6.1/10Fitish provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Fitish review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Fitish
We walked Fitish’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Browse the weight-loss collection and select a product (e.g., compounded semaglutide, compounded tirzepatide, oral tirzepatide, or GLP-1 microdosing).
- 2Complete the telehealth health intake.
- 3A provider evaluates you and issues medication only if clinically appropriate.
- 4Medication is shipped to you.
- Weight-loss product pricing shown upfront, ranging roughly $179-$339 before intake.
- Hybrid platform: also sells skincare, apparel, and other injectables (NAD+, B12, sermorelin) alongside GLP-1 telehealth.
- Site discloses compounded drugs are not FDA-approved and are only issued after provider evaluation.
- Footer includes Telehealth Consent and FitishRX Safety Information links.
- No support phone, email, or hours observed on the pages fetched.
GLP-1 medications Fitish offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
A separate microdose lane is $179/mo and does not titrate up.
A separate microdose lane is $269/mo and does not titrate up.
Ready to get started?
Plans and promotions change often — check Fitish's current pricing and active discounts before you decide.
What we like
- LegitScript certified
- Ships to all US states
- Price includes consult, shipping, and medication
- Injectable and oral tablet formats
- Microdosing option available
Watch-outs
- No physical address disclosed
- Broader wellness/beauty brand — GLP-1 is one product line
- Compounded only — no brand-name options
Fitish: a beauty-and-wellness brand that happens to sell GLP-1s
Fitish (the GLP-1 line runs under its Fitish RX arm) is not a dedicated weight-loss clinic — it's a broader wellness and beauty brand that added compounded semaglutide and tirzepatide as one product line among others. That framing matters, and we'll come back to it. But the core offer is refreshingly simple: one flat price per medication, billed every 28 days, with the consult, the shipping, and the medication itself all folded in. If you've spent any time comparing GLP-1 telehealth, you know how rare that bundled clarity actually is.
Our quick verdict: Fitish is a solid, no-drama pick if you want a single all-in monthly number and you're comfortable buying a compounded GLP-1 from a brand whose main identity is wellness, not medicine. It is not the right pick if you want brand-name Wegovy or Zepbound, a published dose ladder, or a clinic with a physical address you can point to.
How the pricing actually works — one price, everything included
Fitish keeps its money story unusually short. Compounded semaglutide runs $219 for a 28-day supply, and compounded tirzepatide runs a higher flat rate for the same 28 days. There are no separate consultation charges, no membership tier stacked on top, and no shipping line item — the page is explicit that pricing includes consult, shipping, and medication if you're approved. For context, our category median monthly price sits around $169, so Fitish's semaglutide lands close to that midpoint while its tirzepatide sits above it (which is normal — tirzepatide costs more almost everywhere).
What you won't find is a teaser. Fitish doesn't run a slashed first-month promo to pull you in, so the price you see is roughly the price you keep paying. That's a fair trade: no intro-rate sticker shock when month two hits at triple the cost, which is a complaint we hear constantly about promo-led competitors. The flip side is there's also no published per-dose breakdown — Fitish lists a single product price and states it's for a 28-day supply, not a 'same price at every dose' guarantee. If you titrate up, confirm with Fitish that your cost holds before you assume it does.
The medications: compounded only, injectable or oral, plus microdosing
Fitish offers compounded semaglutide and compounded tirzepatide in both injectable and oral-tablet formats — the oral option is genuinely useful for needle-averse patients, and not every telehealth provider carries it. There's also a GLP-1 microdosing program, sold as a separate offering, aimed at people who want lower, gentler dosing rather than the standard weight-loss titration. Between the two molecules, the two delivery formats, and the microdose track, there's more range here than the simple price page suggests.
- Compounded semaglutide — injectable or oral tablet, $219 per 28 days
- Compounded tirzepatide — injectable or oral tablet, flat 28-day price
- GLP-1 microdosing — a distinct lower-dose program for a softer on-ramp
- Everything bundled — consult, shipping, and medication in the one price
One hard limit to be clear about: this is compounded only. Fitish does not offer brand-name Wegovy, Ozempic, Mounjaro, or Zepbound. Compounded medications are made by a pharmacy to order rather than produced by the original manufacturer, and while many patients use them successfully and at lower cost, they are not FDA-approved finished products the way the brand pens are. If brand-name access is a dealbreaker for you, Fitish isn't your provider.
What actually sets Fitish apart
Two things, honestly. First, the all-in flat price with no upsell ladder — what you're quoted is what you owe, and that simplicity is the single most patient-friendly thing about the service. Second, nationwide reach: Fitish ships to all fifty US states, so your eligibility doesn't depend on living in the right place, which trips up plenty of state-limited competitors. Add the oral-tablet option and the microdosing track, and Fitish covers more patient preferences than its stripped-down product pages let on.
Who should choose Fitish — and who should skip it
Choose Fitish if you want a predictable, everything-included monthly bill, you're fine with compounded medication, you'd value an oral or microdose option, or you live somewhere other providers won't ship. It's a clean fit for a budget-conscious, low-fuss patient who doesn't want to decode a pricing table.
Skip it if you want brand-name medication, you need a published dose-by-dose pricing schedule before you commit, or it matters to you that your provider lists a verifiable physical address and a named medical team. Fitish discloses neither a physical address nor a compounding-pharmacy partner in the material we verified, and that's a real transparency gap relative to clinics that name their pharmacy and accreditation up front.
Trust, safety, and oversight
On the positive side, Fitish is LegitScript certified — an independent verification that the operation meets legal and safety standards for selling prescription products online, and a meaningful signal for any telehealth pharmacy. Fitish has an FDA warning letter on file, covered in the regulatory notice below. We rate it as a genuine, verified provider rather than a fly-by-night storefront.
Where our confidence drops is transparency, not legitimacy. Fitish discloses no physical address, and because it's a broader wellness and beauty brand, GLP-1 care is one product line rather than the company's whole focus — you won't find the deep, weight-loss-specific clinical content that single-purpose GLP-1 clinics build out. None of that makes Fitish unsafe; it just means you're trusting the LegitScript stamp and the bundled-care promise more than a richly documented medical operation. See our scoring methodology for how we weigh certification against disclosure.
Bottom line
Fitish is a straightforward, fairly priced way to get compounded semaglutide or tirzepatide with the consult and shipping baked in, available nationwide, with oral and microdose options that many rivals lack. It earns trust through LegitScript certification and a clean record, and it loses points for thin disclosure — no address, no named pharmacy, and a wellness-brand identity rather than a dedicated clinic. If an all-in price and broad availability rank higher for you than brand-name access and clinical depth, Fitish is an easy provider to recommend a closer look at — just confirm your dosing cost holds as you titrate up.
Worth pricing against PeterMD ($215.67/month) and MadeMed ($219/month) before you commit — both sit close to Fitish on cost and formulation.
The Bottom Line
Fitish scores highest on state availability and ease of access.
Ready to start with Fitish?
Starting at $219/month. See current pricing and start your free consultation.
Fitish might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Regulatory notice
Fitish received an FDA warning letter dated June 8, 2026
The letter concerns false & misleading claims/misbranded (telehealth). FDA warning letters are public regulatory communications and do not, on their own, constitute a finding of illegal activity — companies often respond with corrective action.
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Fitish review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Fitish's current pricing
Plans start at $219/month. Start your free consultation to check eligibility and today's price.